1
|
Angelescu MA, Andronic O, Dima SO, Popescu I, Meivar-Levy I, Ferber S, Lixandru D. miRNAs as Biomarkers in Diabetes: Moving towards Precision Medicine. Int J Mol Sci 2022; 23:12843. [PMID: 36361633 PMCID: PMC9655971 DOI: 10.3390/ijms232112843] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 09/27/2022] [Accepted: 10/19/2022] [Indexed: 09/08/2023] Open
Abstract
Diabetes mellitus (DM) is a complex metabolic disease with many specifically related complications. Early diagnosis of this disease could prevent the progression to overt disease and its related complications. There are several limitations to using existing biomarkers, and between 24% and 62% of people with diabetes remain undiagnosed and untreated, suggesting a large gap in current diagnostic practices. Early detection of the percentage of insulin-producing cells preceding loss of function would allow for effective therapeutic interventions that could delay or slow down the onset of diabetes. MicroRNAs (miRNAs) could be used for early diagnosis, as well as for following the progression and the severity of the disease, due to the fact of their pancreatic specific expression and stability in various body fluids. Thus, many studies have focused on the identification and validation of such groups or "signatures of miRNAs" that may prove useful in diagnosing or treating patients. Here, we summarize the findings on miRNAs as biomarkers in diabetes and those associated with direct cellular reprogramming strategies, as well as the relevance of miRNAs that act as a bidirectional switch for cell therapy of damaged pancreatic tissue and the studies that have measured and tracked miRNAs as biomarkers in insulin resistance are addressed.
Collapse
Affiliation(s)
| | - Octavian Andronic
- Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, 050474 Bucharest, Romania
- University Emergency Hospital, 050098 Bucharest, Romania
| | - Simona Olimpia Dima
- Center of Excelence in Translational Medicine (CEMT), Fundeni Clinical Institute, 022328 Bucharest, Romania
- Academy Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University, 040441 Bucharest, Romania
| | - Irinel Popescu
- Center of Excelence in Translational Medicine (CEMT), Fundeni Clinical Institute, 022328 Bucharest, Romania
- Academy Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University, 040441 Bucharest, Romania
| | - Irit Meivar-Levy
- Academy Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University, 040441 Bucharest, Romania
- Orgenesis Ltd., Ness Ziona 7414002, Israel
| | - Sarah Ferber
- Academy Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University, 040441 Bucharest, Romania
- Orgenesis Ltd., Ness Ziona 7414002, Israel
- Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
| | - Daniela Lixandru
- Center of Excelence in Translational Medicine (CEMT), Fundeni Clinical Institute, 022328 Bucharest, Romania
- Department of Biochemistry, University of Medicine and Pharmacy “Carol Davila”, 050474 Bucharest, Romania
| |
Collapse
|
3
|
Iacob R, Herlea V, Savu L, R Florea I, M Ilie V, Terinte-Balcan G, Gherghiceanu M, Uta M, Popa C, Iacob S, V Matei I, Jardan C, Lixandru D, Dima S, Meivar-Levy I, Ferber S, Popescu I. Phenotypic assessment of liver-derived cell cultures during in vitro expansion. Regen Med 2021; 16:33-46. [PMID: 33533664 DOI: 10.2217/rme-2020-0093] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Background: Liver cells represent an attractive source of cells for autologous regenerative medicine. The present study assesses the liver cells' stability during in vitro expansion, as a prerequisite for therapeutic use. Results: The human liver cell cultures in this study were propagated efficiently in vitro for at least 12 passages. No significant changes in morphology, intracellular ultrastructures and characteristic markers expression were found during in vitro expansion of cells from all analyzed donors. However, expanded cells derived from male donors of >60 years old, lost the Y chromosome. Conclusion: Liver-derived cell cultures adopt a proliferative, stable mesenchymal phenotype, through an epithelial to mesenchymal transition process. The molecular and phenotypic changes of the cells during propagation are uniform, despite the heterogeneity of the different donors. Loss of Y chromosome occurs after cells' propagation in elder male donors.
Collapse
Affiliation(s)
- Razvan Iacob
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Center for Digestive Diseases & Liver Transplantation, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Department of Cellular and Molecular Biology and Histology, 'Carol Davila' University of Medicine & Pharmacy Bucharest, Bucharest, 020021, Romania
| | - Vlad Herlea
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Center for Digestive Diseases & Liver Transplantation, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania
| | - Lorand Savu
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania
| | - Ioana R Florea
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania.,Faculty of Biology, University of Bucharest, Bucharest, 030018, Romania
| | - Veronica M Ilie
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania.,Faculty of Biology, University of Bucharest, Bucharest, 030018, Romania
| | - George Terinte-Balcan
- Laboratory of Ultrastructural Pathology, 'Victor Babes' National Institute of Pathology, Bucharest, 050096, Romania
| | - Mihaela Gherghiceanu
- Laboratory of Ultrastructural Pathology, 'Victor Babes' National Institute of Pathology, Bucharest, 050096, Romania
| | - Mihaela Uta
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania
| | - Codruta Popa
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Department of Cellular and Molecular Biology and Histology, 'Carol Davila' University of Medicine & Pharmacy Bucharest, Bucharest, 020021, Romania
| | - Speranta Iacob
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Center for Digestive Diseases & Liver Transplantation, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Department of Cellular and Molecular Biology and Histology, 'Carol Davila' University of Medicine & Pharmacy Bucharest, Bucharest, 020021, Romania
| | - Ioan V Matei
- Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania
| | - Cerasela Jardan
- Department of Cellular and Molecular Biology and Histology, 'Carol Davila' University of Medicine & Pharmacy Bucharest, Bucharest, 020021, Romania
| | - Daniela Lixandru
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Department of Cellular and Molecular Biology and Histology, 'Carol Davila' University of Medicine & Pharmacy Bucharest, Bucharest, 020021, Romania
| | - Simona Dima
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Center for Digestive Diseases & Liver Transplantation, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania
| | - Irit Meivar-Levy
- Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania.,The Sheba Regenerative Medicine, Stem Cell & Tissue Engineering Center, Sheba Medical Center, Tel-Hashomer, 52621, Israel.,Orgenesis Ltd, Ness Ziona, 7414002, Israel
| | - Sarah Ferber
- Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania.,The Sheba Regenerative Medicine, Stem Cell & Tissue Engineering Center, Sheba Medical Center, Tel-Hashomer, 52621, Israel.,Orgenesis Ltd, Ness Ziona, 7414002, Israel.,Department of Human Molecular Genetics & Biochemistry, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 6997801, Israel
| | - Irinel Popescu
- Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Center for Digestive Diseases & Liver Transplantation, Fundeni Clinical Institute, Bucharest, 022328, Romania.,Dia-Cure, Acad. Nicolae Cajal Institute of Medical Scientific Research, Titu Maiorescu University Bucharest, Bucharest, 040441, Romania
| |
Collapse
|